30.06.2014 Views

View conference programme - The British Society for Rheumatology

View conference programme - The British Society for Rheumatology

View conference programme - The British Society for Rheumatology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

17:45 – 19:45 ARMA/BSR/SSR Event – All Welcome Pentland Auditorium<br />

A panel of service users, policy makers and health professionals will discuss the<br />

ARMA Standards of Care project and the need <strong>for</strong> strategies <strong>for</strong> musculoskeletal<br />

conditions. We are pleased to announce that the Rt. Hon. John Reid MP,<br />

Secretary of State <strong>for</strong> Health, is planning to join us <strong>for</strong> the event.<br />

20:00 – 21:30 Satellite symposia<br />

Abbott Immunology: What are your views on current anti-TNF<br />

therapy issues? Tinto/Moorfoot<br />

• Introduction from the chairman. Paul Emery<br />

• Implementing guidelines. Brian Hazleman<br />

• Funding considerations. Gabriel Panayi<br />

• Treatment goals and considerations. Duncan Porter<br />

• Screening and monitoring. David Isenberg<br />

• Cessation of therapy. Iain McInnes<br />

• Summary of key points. Paul Emery<br />

• Question and answer session.<br />

Novartis Pharmaceuticals UK Ltd: Delivering on the COX-2 promise:<br />

towards proven GI safety Sidlaw<br />

20:00 Chair’s welcome G. Nuki, Edinburgh, UK and C. Hawkey,<br />

Nottingham, UK<br />

20:05 Current issues with NSAIDs and COX-2s G. Nuki, Edinburgh, UK<br />

20:20 <strong>The</strong> emerging clinical profile of lumiracoxib<br />

A. Tyndall, Basel, Switzerland<br />

20:40 COX-2 selective inhibitors: learnings from large outcomes studies<br />

D. Walker, Newcastle, UK<br />

20:55 TARGET: the definitive outcomes study? C. Hawkey, Nottingham, UK<br />

21:15 Panel Q&A session<br />

20:25 Chair’s closing remarks G. Nuki, Edinburgh, UK and C. Hawkey,<br />

Nottingham, UK<br />

MSD Ltd: Controversies and Challenges in <strong>Rheumatology</strong> 2004<br />

To be held off-site at the Edinburgh Suite, Sheraton Grand Hotel, Edinburgh<br />

We would like to invite you on behalf of Merck Sharp & Dohme Limited to join<br />

Professor David Blake and Professor Bryan Williams along with a panel of UK<br />

rheumatologists <strong>for</strong> a clinical update followed by a battle of great (and not so<br />

great) minds in the quiz, ‘Controversies and Challenges in <strong>Rheumatology</strong>’.<br />

19:30 Buffet<br />

20:10 Welcome and introduction Chairmen<br />

20:15 Etoricoxib review – key clinical data Chairmen<br />

20:20 Questions from the audience Chairmen and Panel<br />

20:30 <strong>Rheumatology</strong> Quiz<br />

21:20 Satellite close<br />

Panel: Professor Paul Bacon, University Hospital Birmingham<br />

Professor Michael Doherty, City Hospital, Birmingham<br />

Dr Peter Hollingworth, Southmead Hospital, Bristol<br />

Professor Robert Moots, University Hospital Aintree, Liverpool<br />

Professor Gabriel Panayi, Guys Hospital, London<br />

Dr Usha Srinivasan, Princess of Wales Hospital, Bridgend<br />

Dr Doug Veale, St Vincent’s Hospital, Dublin<br />

15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!